Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE Cause Hyperkalaemia? 527 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 527 reports of Hyperkalaemia have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.8% of all adverse event reports for AMLODIPINE.

527
Reports of Hyperkalaemia with AMLODIPINE
0.8%
of all AMLODIPINE reports
86
Deaths
282
Hospitalizations

How Dangerous Is Hyperkalaemia From AMLODIPINE?

Of the 527 reports, 86 (16.3%) resulted in death, 282 (53.5%) required hospitalization, and 132 (25.0%) were considered life-threatening.

Is Hyperkalaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 527 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE Cause?

Hypotension (6,504) Toxicity to various agents (5,554) Completed suicide (5,267) Drug ineffective (4,091) Dyspnoea (3,907) Dizziness (3,536) Intentional overdose (3,427) Fall (3,215) Fatigue (3,141) Headache (2,907)

What Other Drugs Cause Hyperkalaemia?

METFORMIN (2,565) SPIRONOLACTONE (2,518) FUROSEMIDE (2,035) RAMIPRIL (1,383) SACUBITRIL\VALSARTAN (1,192) SULFAMETHOXAZOLE\TRIMETHOPRIM (1,036) LISINOPRIL (948) POTASSIUM (944) BISOPROLOL (850) TACROLIMUS (713)

Which AMLODIPINE Alternatives Have Lower Hyperkalaemia Risk?

AMLODIPINE vs AMLODIPINE BESILATE AMLODIPINE vs AMLODIPINE\ATORVASTATIN AMLODIPINE vs AMLODIPINE\BENAZEPRIL AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL

Related Pages

AMLODIPINE Full Profile All Hyperkalaemia Reports All Drugs Causing Hyperkalaemia AMLODIPINE Demographics